Ornithine transcarbamylase (OTC) deficiency is the most common inborn error of the urea cycle. OTC locus is located in the short arm of Xchromosome. Authors report a case of a woman who gave birth to monozygotic male twins who later died because of severe neonatal-onset hyperammonaemic encephalopathy caused by a novel mutation of OTC gene. Post-mortem liver biopsy was taken from the second twin; afterwards, blood was drawn from the mother for examination. DNA sequence data showed that the mother was a carrier of the same novel mutation that was previously detected in the case of her son. In OTC deficiency, detection of female carriers is important for genetic counselling and eventual prenatal diagnosis.
Introduction
Ornithine transcarbamylase (OTC) deficiency is the most common inborn error of the urea cycle. OTC locus is located in the short arm of X-chromosome. The defect may be due to various point mutations, deletions and insertions in the respective gene. 1 The most common form of the disease occurs as hyperammonaemic encephalopathy in male subjects. Female heterozygotes exhibit wide clinical severities, ranging from being apparently asymptomatic to having profound neurological impairment observed in affected male subjects. Establishing the diagnosis in women at risk for OTC deficiency (OTCD) is important for determining reproductive risks for OTCD women.
Case report
The patient is a 32-year-old asymptomatic woman who had four spontaneous abortions before (in the 12th, 16th, 22nd and 17th gestational week -the sex of the last two fetuses was one male and one female, respectively). In 2003, she had a spontaneous twin pregnancy. On the 31st gestational week, she was sent to the clinic, because of inevitable preterm delivery caused by preterm and premature rupture of membranes, and she gave birth to male twins (1350 and 1490 g) by caesarean section. Monochorial placentation proved that the twins were monozygotic. Both newborns were treated in the Neonatal Intensive Care Unit. On the first day, the first twin needed continuous nasal positive airway pressure ventilation because of respiratory distress and he was treated for a suspicion of intrauterine infection. Blood sugar level and liver enzymes level were normal, and lactate level was slightly elevated. His state deteriorated on day 3. Mechanical ventilation had to be installed because of respiratory distress, muscular hypotonia and abdominal distension. Ultrasound examination of the brain was normal. Further laboratory investigations showed no signs of infection, but revealed a severe hyperammonaemia: the plasma ammonium was 3800 mmol/l (normal, 18 to 48 mmol/l). The newborn received calorie, fluid and electrolyte intravenously (10% dextrose and lipids 1 g/kg/day) and low protein intake in the form of essential amino acids. While the results of plasma amino acid and urine organic acid analyses were awaited, on the 4th day of life he went into deep coma and despite intensive drug (Na-bezoat, diuretics) and anticatabolic treatment he died. Plasma amino acid analysis revealed a low citrulline and arginine level. Argininosuccinic acid was not detectable. In the urine sample, the excretion of orotic acid was massively elevated and the concentration was measured as 3900 mmol/mol creatinine (normal, 0.2 to 6.0). The second twin had the same clinical signs and symptoms as his brother and received the same therapy. Because of an oligo-anuric state, dialysis was planned, but he died before the treatment was started.
A post-mortem liver biopsy was taken from the second twin for further investigations. After the isolation of DNA from liver samples, it was examined by polymerase chain reaction amplification of all 10 exons of the OTC gene including exon-intron boundaries and subsequent single-strand conformation polymorphism analysis. The amplimer of exon 8 revealed an aberrant migration pattern and was further analysed by DNA sequencing. The results indicated a missense point mutation in codon 253 (c.757G>A; RefSeq: NM_000531.3), causing an Ala to Thr coding change (p.Ala253Thr).
In October 2005, the woman came to the genetic counselling, asking advice for a next pregnancy. Hysterosalpingography showed occlusions of the tubes. Blood was drawn from the mother for further investigation and exclusion of OTC carrier state. The DNA sequence data showed that the mother was a carrier of the same mutation that was previously detected in the case of her son.
To prove that the found mutation is not a rare polymorphism in the OTC gene, in 64 unrelated individuals (21 male patients and 43 female patients) authors sequenced more than 100 copies of exon 8: none of them showed the c.757G>A mutation.
Discussion OTCD (OMIM no. 311250) is an X-linked disorder of the urea cycle in which the synthesis of citrulline, and therefore urea, is altered. Affected boys usually die from hyperammonaemia in the first few days of life; in hemizygous male neonates, it usually causes severe disease, presenting with lethargy, vomiting, coma and lifethreatening hyperammonaemia. 2 Clinical expression in carrier female subjects ranges from asymptomatic carriers to neonatal death. Mild forms of the disease can present later, even during adult life. Symptoms and signs may include headache, bizarre behavior, mental retardation, coma, protein avoidance or episodic hyperammonaemia. In female subjects carrying an OTC mutation, clinical manifestations vary because of both allelic heterogeneity and the variable pattern of X-chromosome inactivation in hepatic cells, which correlates well with the OTC activity. 3 Molecular diagnostic methods allow the detection of mildly affected or asymptomatic individuals. Many pathological mutations have been identified within the exons and in exon/intron flanking regions. 1 Few of the mutations are recurrent and associated with CpG hotspots, whereas most of the mutations are family-private and are distributed all over the coding region. 4 Even with sequencing of the entire reading frame and exon/intron boundaries, only about 80% of the mutations are detected in patients with proven OTCD. 1 The remaining probably occurs within the introns or in regulatory domains. DNA-based diagnosis is unable to detect mutations in all cases. Clinical and laboratory diagnosis of partial OTCD during asymptomatic periods is difficult.
In this case, authors found a novel mutation in the affected boy, which has not been described in the Human Gene Mutation Database at the Institute of Medical Genetics in Cardiff (http:// www.hgmd.cf.ac.uk/ac/search/119468.html).
The mother was found to be a carrier of the mutation. The mutation, therefore, was not a de novo mutation in the affected children, but one inherited from the mother.
As the mutation is a missence type mutation, the authors checked more than 100 copies of exon 8 in unrelated individuals in order to prove that this is not a rare polymorphism in the OTC gene.
Prenatal diagnosis for OTCD is currently available from now on for the patient, but this may require termination of pregnancy if affected. In her case, there is a need for in vitro fertilization because of the occlusion of the Fallopian tubes. There is an option for prepregnancy testing, to preselect OTCD-free embryos for transfer, thus avoiding prenatal diagnosis and pregnancy termination. Preimplantation genetic diagnosis for OTCD has been developed 5, 6 and can be offered as an option to this couple.
